BioSpace News Archive

Business

Servier Group Reports Financial Year 2020/2021 Annual Results, R&D Strategy and Pipeline

Olivier Laureau, President of Servier: “In 2020/21, the Servier Group continued to grow despite a difficult environment.

January 18, 2022
·
15 min read
Biotech Bay

HumanFirst Opens Up Atlas Platform to Scale Use of Decentralized Clinical Trials

Offering complimentary access to searchable data on thousands of connected sensors to measure digital biomarkers in clinical trials, HumanFirst gives biopharma a new solution to navigate the rapidly evolving landscape of connected health products.

January 18, 2022
·
2 min read
Biotech Bay

Clinical Data Presented at 2022 North American Neuromodulation Society (NANS) Annual Meeting Reinforce Significant and Durable Benefits of Nevro’s 10 kHz Therapy

SENZA-PDN Randomized Controlled Trial Results Demonstrate Significant and Sustained Outcomes with 10 kHz Therapy at 18-Months Follow-Up.

January 18, 2022
·
8 min read
Biotech Beach

BiologyWorks k(now)™ COVID-19 Clinical Trial Matches 99.1% Accuracy to RT-PCR Tests

BiologyWorks k(now)™ Handheld Molecular Testing Device Among the Most Accurate for COVID-19.

January 18, 2022
·
2 min read
Business

XyloCor Therapeutics Expands Leadership Team with Accomplished Pharmaceutical Executives to Accelerate Clinical Development Programs and Drive Corporate Growth

XyloCor Therapeutics today announced that it has appointed Elizabeth Tarka, M.D. as Chief Medical Officer and A. Brian Davis as Chief Financial Officer.

January 18, 2022
·
4 min read
Business

Overland Pharmaceuticals Appoints Ed Zhang as Chief Executive Officer and Welcomes Industry Leaders John Maraganore and Peter Ho as Strategic Advisors

Overland Pharmaceuticals today announced the appointment of Co-founder Ed Zhang , MBA as full-time Chief Executive Officer after serving as Interim Chief Executive Officer since May 2021.

January 18, 2022
·
6 min read
Business

CorVista Health Appoints Charles R. Bridges as Chief Scientific Officer

CorVista Health, Inc. announces the appointment of Charles R. Bridges, M.D., Sc.D., as Executive Vice President and Chief Scientific Officer.

January 18, 2022
·
3 min read
Drug Development

Sierra Oncology Updates Topline Data Timing for Pivotal Phase 3 Trial of Momelotinib in Myelofibrosis

Sierra Oncology, Inc. today announced it has shortened the timeline to the topline data readout of the MOMENTUM pivotal Phase 3 trial of momelotinib in patients with myelofibrosis.

January 18, 2022
·
4 min read
Genetown

bluebird Provides Update on FDA Review Timelines for Betibeglogene Autotemcel (beti-cel) for Beta-Thalassemia and Elivaldogene Autotemcel (eli-cel) for Cerebral Adrenoleukodystrophy (CALD)

bluebird Provides Update on FDA Review Timelines for Betibeglogene Autotemcel (beti-cel) for Beta-Thalassemia and Elivaldogene Autotemcel (eli-cel) for Cerebral Adrenoleukodystrophy (CALD).

January 18, 2022
·
11 min read
Facial Paralysis Market: Rise in incidence of stroke is expected to drive the market

Facial paralysis refers to the loss of facial muscle movement owing to damage to nerves. Facial muscles of the affected individuals become weak and start to droop.

January 18, 2022
·
5 min read